Art

J-GLOBAL ID：201402287294635083   Reference number：14A0003474

Efficacy of Infliximab in Patients with Intestinal Behcet’s Disease Refractory to Conventional Medication

従来の薬物療法に難治性の腸ベーチェット病患者におけるインフリキシマブの有効性

Author (9)： KINOSHITA Hiroto (Inflammatory Bowel Disease Centre, Yokohama City Univ. Medical Centre, JPN) ,  KUNISAKI Reiko (Inflammatory Bowel Disease Centre, Yokohama City Univ. Medical Centre, JPN) ,  YAMAMOTO Hisae (Inflammatory Bowel Disease Centre, Yokohama City Univ. Medical Centre, JPN) ,  MATSUDA Reikei (Inflammatory Bowel Disease Centre, Yokohama City Univ. Medical Centre, JPN) ,  SASAKI Tomohiko (Inflammatory Bowel Disease Centre, Yokohama City Univ. Medical Centre, JPN) ,  KIMURA Hideaki (Inflammatory Bowel Disease Centre, Yokohama City Univ. Medical Centre, JPN) ,  TANAKA Katsuaki (Gastroenterology Centre, Yokohama City Univ. Medical Centre, JPN) ,  NAGANUMA Makoto (Dep. of Internal Medicine, Keio Univ. School of Medicine, JPN) ,  MAEDA Shin (Dep. of Gastroenterology, Yokohama City Univ., JPN)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 52  Issue： 17  Page： 1855-1862 (J-STAGE)  Publication year： 2013 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *infliximab ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0003474&from=J-GLOBAL&jstjournalNo=U0033A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G)

Reference (23)：

• 1. Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol 87: 1175-1183, 2003.
• 2. Kobayashi K, Ueno F, Bito S, et al. Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach. J Gastroenterol 42: 737-745, 2007.
• 3. Jung YS, Yoon JY, Lee JH, et al. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behçet's disease. Inflamm Bowel Dis 17: 1594-1602, 2011.
• 4. Naganuma M, Iwao Y, Inoue N, et al. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet's disease. Am J Gastroenterol 95: 2848-2851, 2000.
• 5. Ford AC, Sandborn WJ, Khan KJ, Hanauer SB, Talley NJ, Moayyedi P. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 106: 644-659, quiz 660, 2011.

Terms in the title (5)： 薬物療法 ,  腸ベーチェット病 ,  患者 ,  インフリキシマブ ,  有効性